本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

44.12
+0.50001.15%
成交量:10.62萬
成交額:469.50萬
市值:21.17億
市盈率:-14.45
高:44.90
開:44.30
低:43.36
收:43.62
52周最高:52.93
52周最低:22.73
股本:4,797.83萬
流通股本:3,039.38萬
量比:0.33
換手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-3.0525
每股收益(LYR):-2.8633
淨資產收益率:-39.96%
總資產收益率:-25.78%
市淨率:5.01
市盈率(LYR):-15.41

資料載入中...

2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/14

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/10

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

SEC問詢函

Form CORRESP - Correspondence
2024/06/05

SEC問詢函

Form CORRESP - Correspondence
2024/06/03

SEC問詢函

Form CORRESP - Correspondence
2024/06/03

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/30

SEC問詢函

Form CORRESP - Correspondence
2024/05/18

SEC問詢函

Form CORRESP - Correspondence
2024/05/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933